Open AccessS0464 Cost Reduction Associated With Improvement in Work Productivity Loss From Ustekinumab Treatment by Disease Severity States in Crohn's Disease Patients: Results From the IM-UNITI Clinical Trial
Author(s) -
Amanda Teeple,
Erik Muser,
Dominik Naessens,
Béranger Lueza,
Zahra Kamal,
Astrid Foix Colonier,
Claudia Carlucci
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000703904.93768.fb
Subject(s) - medicine , presenteeism , absenteeism , work productivity , placebo , ustekinumab , disease , crohn's disease , productivity , physical therapy , adalimumab , alternative medicine , management , pathology , economics , macroeconomics